Skip to content
10-Q

Quarterly Report

SYRA HEALTH CORP. SYRA

0001493152-25-022023

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 11.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 11.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 11.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.79M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$158.55K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.72M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.98M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.4M
Stockholders Equity Q3 2025 · Sep 30, 2025 $2.21M
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.41M
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.46M
Stockholders Equity Q3 2025 · Dec 31, 2024 $2.88M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.09M
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.45M
Stockholders Equity Q3 2025 · Dec 31, 2023 $4.01M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.05M
Current Liabilities Q3 2025 · Dec 31, 2024 $613.55K
Total Liabilities Q3 2025 · Sep 30, 2025 $1.05M
Total Liabilities Q3 2025 · Dec 31, 2024 $800.76K
Current Assets Q3 2025 · Sep 30, 2025 $3.21M
Current Assets Q3 2025 · Dec 31, 2024 $3.35M
Total Assets Q3 2025 · Sep 30, 2025 $3.26M
Total Assets Q3 2025 · Dec 31, 2024 $3.68M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.06
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.06
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 −$0.06
Eps Basic Q3 2025 · Sep 30, 2024 −$0.06
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Sga Expense Q3 2025 · Sep 30, 2025 $252.38K
Sga Expense Q3 2025 · Sep 30, 2025 $828.74K
Sga Expense Q3 2025 · Sep 30, 2024 $288.31K
Sga Expense restated Q3 2025 · Sep 30, 2024 $1.27M
Rd Expense Q3 2025 · Sep 30, 2025 $816
Rd Expense Q3 2025 · Sep 30, 2025 $67.7K
Rd Expense Q3 2025 · Sep 30, 2024 $34.82K
Rd Expense Q3 2025 · Sep 30, 2024 $590.26K
Net Income Q3 2025 · Sep 30, 2025 −$225.9K
Net Income Q3 2025 · Sep 30, 2025 −$761.76K
Net Income Q3 2025 · Jun 30, 2025 −$63.6K
Net Income Q3 2025 · Mar 31, 2025 −$472.27K
Net Income Q3 2025 · Sep 30, 2024 −$417.54K
Net Income Q3 2025 · Sep 30, 2024 −$3.25M
Net Income Q3 2025 · Jun 30, 2024 −$1.39M
Net Income Q3 2025 · Mar 31, 2024 −$1.45M
Operating Income Q3 2025 · Sep 30, 2025 −$232.17K
Operating Income Q3 2025 · Sep 30, 2025 −$768.66K
Operating Income Q3 2025 · Sep 30, 2024 −$428.91K
Operating Income Q3 2025 · Sep 30, 2024 −$3.26M
Gross Profit Q3 2025 · Sep 30, 2025 $554.54K
Gross Profit Q3 2025 · Sep 30, 2025 $1.9M
Gross Profit Q3 2025 · Sep 30, 2024 $668.3K
Gross Profit restated Q3 2025 · Sep 30, 2024 $1.32M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.13M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $3.6M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.59M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $4.66M
Revenue Q3 2025 · Sep 30, 2025 $1.69M
Revenue Q3 2025 · Sep 30, 2025 $5.49M
Revenue Q3 2025 · Sep 30, 2024 $2.25M
Revenue Q3 2025 · Sep 30, 2024 $5.98M
Capex Q3 2025 · Sep 30, 2024 $11.11K